A Phase 2 trial of STC-004.
Latest Information Update: 07 Feb 2025
At a glance
- Drugs STC 004 (Primary)
- Indications Pain
- Focus Therapeutic Use
Most Recent Events
- 07 Feb 2025 New trial record
- 04 Feb 2025 According to the SiteOne Therapeutics media release, company will be advancing STC-004 into Phase 2 trials in the second half of this year